Elios Therapeutics, LLC, is a biopharmaceutical company developing a portfolio of innovative therapeutic cancer vaccines targeting unmet medical needs across a broad range of tumor types. Elios’ lead product is the TLPO vaccine, an autologous therapeutic cancer vaccine designed to stimulate the immune system to recognize tumor cells and fight a patient’s specific cancer. Therapeutic cancer vaccines are an attractive immunotherapy because of their potential safety, specificity, and long-lasting response due to stimulation of immune memory.
Company Details
- Employees
- 3
- Founded
- 2014
- Address
- 5900 Southwest Parkway, Austin,texas,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Austin, Texas
Elios Therapeutics, Llc Questions
Elios Therapeutics, Llc's website is http://www.eliostherapeutics.com/
Elios Therapeutics, Llc's LinkedIn profile is https://www.linkedin.com/company/elios-therapeutics
Elios Therapeutics, Llc has
3 employees.
View email and phone details for 3
employees at Elios Therapeutics, Llc.
Elios Therapeutics, Llc's industry is
Pharmaceutical Manufacturing
Elios Therapeutics, Llc's top competitors are
Orbis Health Solutions, Llc,
Durastat,
Tvardi Therapeutics,
Babson Diagnostics,
Alaunos Therapeutics,
Curtana Pharmaceuticals,
Angstrom Bio, Inc.,
Aminex Therapeutics,
Alafair Biosciences, Inc.,
Maxwell Biosciences.
Elios Therapeutics, Llc's categories are Pharmaceutical Manufacturing
Elios Therapeutics, Llc's founding year is 2014
